Exciting news of mRNA vaccine research against monkeypox has been coming out since the beginning of 2024: February 15, the...

Thymic Stromal Lymphopoietin (TSLP), is a pleiotropic cytokine of the IL-2 family, closely related to IL-7, playing a significant role...

Casgevy, the world's first drug based on CRISPR/Cas9 gene-editing technology, was approved for market release at the end of 2023,...

Function and Signaling Pathway of Integrin αvβ6 Integrin αvβ6 (hereinafter referred to as αvβ6) belongs to the integrin family of...

On October 7, 2024, Scholar Rock announced that the Phase III clinical trial (SAPPHIRE) of Apitegromab (SRK-015) met its primary...

In July 2023, Eli Lilly made a nearly $2 billion bet on Versanis' ActRII inhibitor, Bimagrumab, citing its ability to...

FDA Official Guidelines On January 31, 2024, the FDA CBER officially released the "Human Gene Therapy Products Incorporating Human Genome...

Since December 2023, there have been several positive updates about drugs targeting MSLN. On December 19th, RemeGen announced that the...

Since its debut in 2016, base editing technology has opened up new perspectives and methods for drug development with its...

Colorectal cancer (CRC) is recognized as one of the most common and life-threatening malignancies, with an increasing proportion of advanced...

Through decades of rapid development, gene editing technology has officially entered the CRISPR 2.0 era, with new technologies such as...

Neuroendocrine neoplasms/tumors (NENs or NETs) are rare tumors that originate from specialized cells called neuroendocrine cells. These cells have characteristics...